Chimerix Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	112.31	119.43	60.51	20.27	11.8	7.5
Revenue Growth (YoY)	31.17%	97.38%	198.44%	71.84%	57.31%	-
Cost of Revenue	106.15	109.93	61.92	24.82	14.5	8.2
Gross Profit	6.16	9.49	-1.41	-4.55	-2.7	-0.7
Selling, General & Admin	22.29	37.37	110.7	42.04	26.64	15.06
Research & Development	19.71	24.04	20.85	3.29	2.96	2.18
Operating Expenses	50.51	69.75	135.31	46.35	30.65	20.06
Operating Income	-44.35	-60.26	-136.72	-50.9	-33.35	-20.76
Interest Expense	-10.84	-8.62	-2.97	-0.6	-2.14	-1.57
Other Non Operating Income (Expenses)	-3.75	-8.52	-53.94	-28.81	-0.99	-1.11
EBT Excluding Unusual Items	-58.94	-77.39	-193.63	-80.31	-36.48	-23.44
Merger & Restructuring Charges	-3.2	-3.2	-	-	-	-
Impairment of Goodwill	-	-	-60.05	-	-	-
Other Unusual Items	5.44	5.4	-0.33	5.95	0.69	-
Pretax Income	-56.7	-75.2	-254	-74.36	-35.78	-23.44
Income Tax Expense	-0.29	-0.29	-3.3	-	-	-
Net Income	-56.41	-74.91	-250.7	-74.36	-35.78	-23.44
Net Income to Common	-56.41	-74.91	-250.7	-74.36	-35.78	-23.44
Shares Outstanding (Basic)	14	13	6	2	27	15
Shares Outstanding (Diluted)	14	13	6	2	27	15
Shares Change (YoY)	82.07%	128.98%	192.50%	-92.99%	84.58%	-
EPS (Basic)	-3.92	-5.80	-44.46	-38.58	-1.30	-1.57
EPS (Diluted)	-3.92	-5.80	-44.46	-38.58	-1.30	-1.57
Free Cash Flow	-69.63	-66.08	-71.96	-28.14	-24.07	-8.91
Free Cash Flow Per Share	-4.84	-5.12	-12.76	-14.60	-0.88	-0.60
Gross Margin	5.48%	7.95%	-2.33%	-22.44%	-22.86%	-9.32%
Operating Margin	-39.49%	-50.46%	-225.97%	-251.08%	-282.68%	-276.77%
Profit Margin	-50.23%	-62.72%	-414.34%	-366.79%	-303.31%	-312.49%
Free Cash Flow Margin	-62.00%	-55.33%	-118.93%	-138.78%	-203.99%	-118.81%
EBITDA	-35.84	-51.92	-132.96	-49.88	-32.3	-17.93
EBITDA Margin	-31.91%	-43.47%	-219.75%	-246.01%	-273.76%	-239.07%
D&A For EBITDA	8.51	8.34	3.76	1.03	1.05	2.83
EBIT	-44.35	-60.26	-136.72	-50.9	-33.35	-20.76
EBIT Margin	-39.49%	-50.46%	-225.97%	-251.08%	-282.68%	-276.77%

Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q